AU2012244278C1 - Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof - Google Patents

Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof Download PDF

Info

Publication number
AU2012244278C1
AU2012244278C1 AU2012244278A AU2012244278A AU2012244278C1 AU 2012244278 C1 AU2012244278 C1 AU 2012244278C1 AU 2012244278 A AU2012244278 A AU 2012244278A AU 2012244278 A AU2012244278 A AU 2012244278A AU 2012244278 C1 AU2012244278 C1 AU 2012244278C1
Authority
AU
Australia
Prior art keywords
compound
polymorph
formula
tiacumicins
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012244278A
Other versions
AU2012244278B2 (en
AU2012244278A1 (en
Inventor
Tessie Mary Che
Yu-Hung Chiu
Yoshi Ichikawa
Alex Romero
Youe-Kong Shue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Optimer Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US60/881,950 priority Critical
Priority to US11/831,886 priority
Priority to AU2008209580A priority patent/AU2008209580B2/en
Application filed by Optimer Pharmaceuticals LLC filed Critical Optimer Pharmaceuticals LLC
Priority to AU2012244278A priority patent/AU2012244278C1/en
Publication of AU2012244278A1 publication Critical patent/AU2012244278A1/en
Application granted granted Critical
Publication of AU2012244278B2 publication Critical patent/AU2012244278B2/en
Publication of AU2012244278C1 publication Critical patent/AU2012244278C1/en
Assigned to MERCK SHARP & DOHME CORP. reassignment MERCK SHARP & DOHME CORP. Request for Assignment Assignors: OPTIMER PHARMACEUTICALS, INC.
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links